Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension

Bratislava Medical Journal

Volumn 111, Issue 11, 2010, Pages 595-598

  Jansa, P ^a   Hrachovinova, I ^b   Ambroz, D ^a   Maresova, J ^a   Polacek, P ^a   Simkova, I ^c   Linhart, A ^a   Aschermann, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Anticoagulant therapy; Pulmonary arterial hypertension; Thrombin generation

Indexed keywords

ANTICOAGULANT AGENT; THROMBIN;

ARTICLE; BLOOD; FEMALE; HUMAN; IDIOPATHIC PULMONARY HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PULMONARY HYPERTENSION;

ANTICOAGULANTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; THROMBIN;

EID: 78650011521     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Frank H, Mlczoch JJ, Huber K et al. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997; 112: 714-721.
2. Badesch DB, Abman SH, Ahearn GS et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (Suppl 1): 35S-62S.
3. Galie N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278.
4. Turpie AGG, Gunstensen J, Hirsh J et al. Randomised comparison of two intensites of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988; 1: 1242-1245.
5. The Boston Area Anticoagulation Trial for Atrial Fibrilation Investiogators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrilation. N Engl J Med 1990; 323: 1505-1511.
6. Altman R, Rouvier J, Gurfinkel E et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991; 101: 427-431.
7. Gatt A, Veen van JJ, Woolley AM et al. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost 2008; 100: 350-355.
8. Roman A, Rodes-Cabau J, Lara B et al. Clinico-haemodynamic study and treatment of 44 patients with primary pulmonary hypertension. Med Clin (Barc) 2002; 118: 761-766
9. Fuster V, Steele PM, Edwards WD et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70: 580-587.
10. Kawut SM, Horn EM, Berekashvili KK et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199-203.
11. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
12. Badesch DB, Abman SH, Simonneau G et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-1928.